IDRA stock forecast
Our latest prediction for Idera Pharmaceuticals, Inc.'s stock price was made on the Jan. 7, 2020 when the stock price was at 1.80$.
In the short term (2weeks), IDRA's stock price should underperform the market by -0.95%. During that period the price should oscillate between -11.01% and +18.87%.
In the medium term (3months), IDRA's stock price should underperform the market by -5.65%. During that period the price should oscillate between -43.52% and +52.03%.Get email alerts
About Idera Pharmaceuticals, Inc.
Idera Pharmaceuticals, Inc. is a clinical stage biopharmaceutical company, which focuses on the clinical development, and commercialization of drug candidates for both oncology and rare disease indications. The company was founded by Paul C. Zamecnik, Sudhir A. Agrawal, and James B. Wyngaarden on May 25, 1989 and is headquartered in Cambridge, MA.
At the moment the company generates 2M USD in revenues.
On its last earning announcement, the company reported a loss of -1.61$ per share.
The book value per share is 3.13$
Three months stock forecastJan. 7, 2020
|Revenue USD||Gross Margin||Operating Income||Operating Margin||Net Income||Earnings Per Share||Dividends||Payout Ratio||Shares||Book Value Per Share||Operating Cash Flow||Cap Spending||Free Cash Flow|